PDF
Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage
Organization: United States Centers for Disease Control (CDC)Published: 2021
"COVID-19 vaccines authorized in the United States are effective against severe illness and death from SARS-CoV-2 infection; however, current U.S. coverage is uneven. Implementation of layered prevention strategies reduces SARS-CoV-2 transmission.
Given the spread of the highly transmissible Delta variant, local decision-makers should assess the following factors to inform the need for layered prevention strategies across a range of settings: level of SARS-CoV-2 community transmission, health system capacity, vaccination coverage, capacity for early detection of increases in COVID-19 cases, and populations at risk for severe outcomes from COVID-19.
Although increasing COVID-19 vaccination coverage remains the most effective means to achieve control of the pandemic, additional layered prevention strategies will be needed in the short-term to minimize preventable morbidity and mortality." - United States Centers for Disease Control
Product Type: Guide
Category:
Program Planning and Delivery,Program Delivery and Evaluation,Guides,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19,Vaccine Monitoring and Surveillance,Vaccination Coverage and Goals Program Planning and DeliveryProgram Delivery and Evaluation
Guides
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Vaccine Monitoring and Surveillance
Vaccination Coverage and Goals
Policy Makers
Population: Children (All)
Adults
High Risk Adults
Healthcare Personnel
Pregnant and Breastfeeding People
Seniors
Region: United States
LinkResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.